口罩概念股再度走強 龍頭股份等多股漲停
格隆匯1月21日丨受疫情擴散影響,口罩等相關防護產品的銷量走俏。口罩概念股再度走強,龍頭股份、泰達股份、振德醫療、江南高纖開盤漲停。
淘寶的全網熱榜顯示,防病毒口罩已衝上第四名;京東的口罩熱賣榜顯示,在售的20多款熱銷口罩中,銷量排名第二的霍尼韋爾口罩(KN95級別)、銷量排名第四的3M帶閥防護口罩(KN95級別)和排名第六的穩健醫用護理口罩已顯示缺貨。不過口罩的供貨整體穩健,暫時未出現大規模缺貨的情況,拼多多、蘇寧等電商平台也有大量口罩銷售中。
此外,淘寶和京東等電商平台搜索數據顯示,目前3M品牌旗艦店內的部分KN95系列口罩均已出現售罄斷貨情況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.